Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.

MLA

Nakowitsch, Sabine, et al. “Mutations Affecting the Stability of the Haemagglutinin Molecule Impair the Immunogenicity of Live Attenuated H3N2 Intranasal Influenza Vaccine Candidates Lacking NS1.” Vaccine, vol. 29, no. 19, Apr. 2011, pp. 3517–24. EBSCOhost, https://doi.org/10.1016/j.vaccine.2011.02.100.

APA

Nakowitsch, S., Wolschek, M., Morokutti, A., Ruthsatz, T., Krenn, B. M., Ferko, B., Ferstl, N., Triendl, A., Muster, T., Egorov, A., & Romanova, J. (2011). Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1. Vaccine, 29(19), 3517–3524. https://doi.org/10.1016/j.vaccine.2011.02.100

Chicago

Nakowitsch, Sabine, Markus Wolschek, Alexander Morokutti, Tanja Ruthsatz, Brigitte M Krenn, Boris Ferko, Nicole Ferstl, et al. 2011. “Mutations Affecting the Stability of the Haemagglutinin Molecule Impair the Immunogenicity of Live Attenuated H3N2 Intranasal Influenza Vaccine Candidates Lacking NS1.” Vaccine 29 (19): 3517–24. doi:10.1016/j.vaccine.2011.02.100.